TORC1 Antibody (505531) [mFluor Violet 450 SE]

Product Discontinued

TORC1 Antibody (505531) [mFluor Violet 450 SE] Summary

• Immunogen: E. coli-derived recombinant mouse TORC1
  Gln384-Gln471
  Accession # Q68ED7
• Specificity: Detects mouse TORC1 in direct ELISAs.
• Isotype: IgG2a
• Clonality: Monoclonal
• Host: Rat
• Gene: CRTC1
• Purity: Protein A or G purified from hybridoma culture supernatant

Applications/Dilutions

• Dilutions:
  • Immunohistochemistry
• Application Notes: Optimal dilution of this antibody should be experimentally determined.

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark.
• Buffer: 50mM Sodium Borate
• Preservative: 0.05% Sodium Azide
• Purity: Protein A or G purified from hybridoma culture supernatant

Notes

mFluor(TM) is a trademark of AAT Bioquest, Inc. This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.

Alternate Names for TORC1 Antibody (505531) [mFluor Violet 450 SE]

• CREB regulated transcription coactivator 1
• CRTC1
• FLJ14027WAMTP1
• KIAA0616Transducer of regulated cAMP response element-binding protein 1
• MECT1
• MECT1CREB-regulated transcription coactivator 1
• mucoepidermoid carcinoma translocated 1
• Mucoepidermoid carcinoma translocated protein 1
• TORC1
• TORC1TORC-1
• Transducer of CREB protein 1
• transducer of regulated cAMP response element-binding protein (CREB) 1
• WAMTP1

Background

MECT1 (also known as MucoEpidermoid Carcinoma Translocated 1, Transducer of regulated cAMP response element-binding protein 1, TORC1, and Transducer of CREB protein 1) is a nuclear protein that functions as a transcriptional coactivator for CREB1, which activates transcription through both consensus and variant cAMP response element (CRE) sites. MECT1does not appear to modulate CREB1 DNA-binding activity but enhances the interaction of CREB1 with TAF4/TAFII-130. MECT1 translocates with MAML2 (MasterMind-Like Protein 2) to yield a fusion oncogene: t(11;19) (q21;p13). This translocation occurs in mucoepidermoid carcinomas, benign Warthin tumors and clear cell hidradenomas. The novel fusion product that results disrupts the Notch signaling pathway. The fusion protein consists of the N-terminus of MECT1 joined to the C-terminus of MAML2. The reciprocal fusion protein consisting of the N-terminus of MAML2 joined to the C-terminus of MECT1 has been detected in a small number of mucoepidermoid carcinomas. Multiple isoforms have been reported for the MECT1 protein.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Gene Symbol: CRTC1